Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2022 Financial Results on May 12, 2022

Rhea-AI Summary

Marinus Pharmaceuticals (MRNS) announced plans to release its Q1 financial results on May 12, 2022, after market close. A conference call will follow at 4:00 p.m. ET to provide a business update and discuss these results. The company focuses on innovative therapies for seizure disorders, with Ganaxolone as its leading neuroactive steroid GABA_A receptor modulator, available in both IV and oral forms for adults and children.

RADNOR, Pa.--(BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial results for the first quarter ended March 31, 2022 after the market closes on May 12, 2022. The Company will host a conference call at 4:00 p.m. ET on May 12, 2022 to provide a business update and discuss the financial results.

Thursday, May 12: 4:00 p.m. Eastern Time

• Domestic: (888) 550-5280
• International: (646) 960-0813
• Webcast Link: https://events.q4inc.com/attendee/993378901
• Conference ID: 2696394

About Marinus Pharmaceuticals

Marinus is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders. Ganaxolone is a neuroactive steroid GABA_A receptor modulator that acts on a well-characterized target in the brain known to have anti-seizure effects. It is being developed in IV and oral dose formulations intended to maximize therapeutic reach to adult and pediatric patient populations in both acute and chronic care settings. For more information visit www.marinuspharma.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220420005372/en/

Sasha Damouni Ellis

Vice President, Corporate Affairs & Investor Relations

Marinus Pharmaceuticals, Inc.

484-253-6792

sdamouni@marinuspharma.com

Source: Marinus Pharmaceuticals

FAQ

When will Marinus Pharmaceuticals release its Q1 2022 financial results?

Marinus Pharmaceuticals will release its Q1 2022 financial results on May 12, 2022, after the market closes.

What time is the conference call for Marinus Pharmaceuticals Q1 results?

The conference call for Marinus Pharmaceuticals Q1 results is scheduled for 4:00 p.m. ET on May 12, 2022.

What is Ganaxolone and its significance for Marinus Pharmaceuticals?

Ganaxolone is a neuroactive steroid GABA_A receptor modulator being developed by Marinus Pharmaceuticals to treat seizure disorders.